• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 478060 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414073632 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414073632 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Possible Bearish Inside Day Candle Pattern Detected for GlaxoSmithKline (NYSE:GSK)

Published on Mon, 04/15/2013 - 07:27
By Peter Chu

Analyzing the price chart for GlaxoSmithKline (NYSE:GSK) has revealed a potential bearish inside day candle pattern. Yesterday's price range of $48.15 and $48.50 is within the prior day's high and low of the day. This trading action often signifies indecision by bulls and bears to drive prices higher or lower and often implies a possible change in trend. Owners of GlaxoSmithKline may want to consider a possible hedge in the event a pullback occurs. Look for confirmation in the next few trading days.

GlaxoSmithKline plc is a research-based pharmaceutical group that develops, manufactures and markets vaccines, prescription and over-the-counter medicines, as well as health-related consumer products. The Group, which also provides laboratory testing and disease management services, specializes in treatments for respiratory, central nervous system, gastro-intestinal and genetic disorders

In the past 52 weeks, GlaxoSmithKline share prices have been bracketed by a low of $41.68 and a high of $48.55 and closed yesterday at $48.47, 16% above that low price. The 200-day and 50-day moving averages have moved 0.11% higher and 0.61% higher over the past week, respectively.

GlaxoSmithKline (NYSE:GSK) is currently priced 0.2% above its average consensus analyst price target of $48.39. The stock should find initial support at its 50-day moving average (MA) of $45.68 and further support at its 200-day MA of $45.26.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

RBC Capital Made the Right Call, eBay 0....

One week ago eBay (NASDAQ:EBAY) was downgraded from Outperform to Sector Perform at RBC ...

CRT Capital Made the Right Call, NetFlix...

A week ago, CRT Capital downgraded NetFlix from Buy to Fair Value. The shares closed a ...

Jefferies's Rating Change Only Had Short...

Jefferies upgraded NetFlix (NASDAQ:NFLX) from Underperform to Hold a week ago. The sha ...

Lululemon Athletica In Retrospect: Share...

A week ago, Macquarie downgraded Lululemon Athletica from Neutral to Underperform. The ...

Analyst Rating Flashback: Baidu Up 6.6% ...

One week ago Baidu (NASDAQ:BIDU) was upgraded from Perform to Outperform at Oppenheimer ...

Analyst Rating In Review: LifePoint Hosp...

RW Baird upgraded LifePoint Hospitals (NASDAQ:LPNT) from Neutral to Outperform a week a ...

Stratasys Fulfills the Promise: Up 1.8% ...

Stephens upgraded Stratasys (NASDAQ:SSYS) from Equal Weight to Overweight a week ago. ...

Gulfport Energy Up 7.7% Since RBC Capita...

RBC Capital upgraded Gulfport Energy (NASDAQ:GPOR) from Sector Perform to Outperform a ...